Amendment No. 1 to the Exclusive License Agreement
Exhibit 10.12B
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Amendment No. 1
to the
This Amendment No. 1, dated as of August 4, 2014, is entered into between Seattle Children’s Hospital d/b/a Seattle Children’s Research Institute, a Washington non-profit corporation (“Licensor”) and Juno Therapeutics, Inc., a Delaware corporation (“Licensee”)
• | Licensor and Licensee previously entered into an Exclusive License Agreement, dated as of February 13, 2014 (“Original Agreement”). |
• | Licensor and Licensee want to amend the Original Agreement to add patent application(s) to the Licensed Patents, all as set forth below. |
Accordingly, the parties agree as follows:
1. Exhibit A. Exhibit A is hereby amended to add the following patent application(s):
[***] | [***] | [***] | ||
[***] | [***] | [***] | ||
[***] | [***] | [***] |
2. Exhibit A Restated. Exhibit A, in full, now reads as follows:
[***] | [***] | [***] | ||
[***] | [***] | [***] | ||
[***] | [***] | [***] | ||
[***] | [***] | [***] | ||
[***] | [***] | [***] | ||
[***] | [***] | [***] |
3. Full Force and Effect. Except as modified by this Amendment No. 1, all other terms of the Original Agreement will remain in full force and effect.
Seattle Children’s Hospital d/b/a Seattle Children’s Research Institute and Juno Therapeutics, Inc., Exclusive License Agreement, Amendment 1, Page 2 of 2
JUNO THERAPEUTICS, INC. | SEATTLE CHILDREN’S HOSPITAL D/B/A SEATTLE CHILDREN’S RESEARCH INSTITUTE | |||||||
By: | /s/ X. Xxxxxx |
By: | /s/ Xxxxx X. Xxxxxxxxx, PhD | |||||
Name: | X. Xxxxxx |
Name: | Xxxxx X. Xxxxxxxxx, PhD | |||||
Title: | C.E.O. |
Title: | President, Seattle Children’s Research Institute |
2